Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

A. Bronden, H. H. Nerild, C. C. Nexoe-Larsen, P. H. Hellmann, M. Baekdal, I. M. Gether, M. P. Gillum, B. Hartmann, L. B. Knudsen, L. V. Jacobsen, J. F. Rehfeld, J. J. Holst, T. Vilsboll, D. P. Sonne, F. K. Knop

Research output: Contribution to journalConference abstract in journalResearch

Original languageEnglish
Article number177
JournalDiabetologia
Volume64
Issue numberSUPPL 1
Pages (from-to)94-94
ISSN0012-186X
DOIs
Publication statusPublished - 2021

Cite this